kotak-logo
Rubicon Research  Share Price

Rubicon Research Share Price

921.35
-6.20 (-0.67%)
NSE: RUBICON | BSE: 544578 | Miscellaneous | Small Cap| as on 21 Apr, 2026 • 03:29 PM IST
Buywith MTF at 3.33x leverage

Rubicon Research Share Price Today


As of 21 Apr 2026, Rubicon Research share price is ₹921.4. The stock opened at ₹940 and had closed at ₹927.6 the previous day. During today’s trading session, Rubicon Research share price moved between ₹915.95 and ₹952.70, with an average price for the day of ₹934.33. Over the last 52 weeks, the stock has recorded a low of ₹570.75 and a high of ₹952.70. In terms of performance, Rubicon Research share price has increased by 52.3% over the past six months and has declined by 0% over the last year.

Rubicon Research Stock Performance

1W Return12.39
1Y Return0.00
Today's Low915.95
Prev. Close927.55
Mkt Cap (Cr.)15,281.42
1M Return17.68
3Y Return0.00
52-Week High952.7
Open940.00
PE Ratio96.67
6M Return50.58
Today's High952.7
52-Week Low570.75
Face Value1

Rubicon Research Company background

Founded in: 1999
Rubicon Research Limited was incorporated on May 6, 1999, as a Private Company as Rubicon Consultants Private Limited, with the RoC. Subsequently, the Companys name was changed from Rubicon Consultants Private Limited to Rubicon Research Private Limited to which a fresh Certificate of Incorporation was issued by the RoC dated September 2, 2002. The Companys status got converted from a Private Company to a Public Company, the name was changed from Rubicon Research Private Limited to Rubicon Research Limited. A fresh Certificate of Incorporation dated July 23, 2024 was issued by the Central Processing Centre, Manesar, Haryana. Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. The Company is driven by innovation through focused research and development, with an increasing portfolio of specialty products and drugdevice combination products targeting regulated markets, particularly, the United States. It has obtained its GMP manufacturing facilities at Ambernath and Satara in Maharashtra.The Company commenced manufacturing of certain special drugs in Ambernath Manufacturing Facility in 2011. In 2016, the Company acquired majority stake by ECP III Pte Ltd. Further, it acquired majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd. in 2019. In 2021, the Company acquired the business of Meditab Specialities Limited on slump sale as a going concern. In FY 2024, the Company acquired Validus, a New Jersey headquartered marketer of brand name formulation products in the US. It commenced the manufacturing of nasal products at Ambernath Plant in 2024. The Company has acquired Pithampur Manufacturing Facility from Alkem Laboratories Ltd in 2025. The Company came up with its initial public offering of 28,405,841 equity shares of face value of Re 1 each, by raising funds aggregating to Rs 1378 crores, comprising a fresh issue of 10,313,058 equity shares aggregating to Rs 500 crores and the offer for sale of 18,092,783 equity shares aggregating to Rs 878 crores on October 13, 2025.

Rubicon Research Financial Highlights


For the full year FY2025–2026, revenue reached ₹1296.22 crore and profit touched at ₹134.36 crore. As of Mar '26, Rubicon Research’s market capitalisation stood at ₹15,281.42 crores. Shareholding as of Mar '26 shows promoters holding 59.9%, with FIIs at 7.5%, DIIs at 10.1%, and public at 22.6%.
Read More

Rubicon Research Fundamental

Market Cap (in crs)

15,281.42

Face Value

1

Turnover (in lacs)

4,139.02

Key Metrics

Qtr Change %
38.8
Dividend yield 1yr %
0

Rubicon Research Key Financials

View more
Loading chart...
Rubicon Research Quarterly Revenue
Rubicon Research Yearly Revenue
Rubicon Research Quarterly Net Profit/Loss
Rubicon Research Yearly Net Profit/Loss

Rubicon Research Result Highlights

  • Rubicon Research reported a 16.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were up by 14.0% QoQ and - - YoY.

  • The net profit increased 35.2% QoQ and - - YoY.

  • The earnings per share (EPS) of Rubicon Research stood at 4.41 during Q3 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Rubicon Research Technical Analysis

Moving Averages Analysis
921.35
Current Price
Bullish Moving Averages
13
Bearish Moving Averages
0
5 EMA
880.60
10 EMA
850.70
12 EMA
842.70
20 EMA
821.80
26 EMA
811.50
50 EMA
782.10
100 EMA
731.10
EMA EMA
Delivery & Volume
Loading chart...

Day

47.70%

Week

36.00%

Month

49.00%

Delivery & Volume

919.10
Pivot
Resistance
First Resistance
947.15
Second Resistance
966.75
Third Resistance
994.80
Support
First Support
899.50
Second support
871.45
Third Support
851.85
Relative Strength Index
74.63
Money Flow Index
86.14
MACD
31.25
MACD Signal
18.33
Average True Range
36.37
Average Directional Index
35.96
Rate of Change (21)
24.07
Rate of Change (125)
0.00
Compare

Rubicon Research Shareholding Pattern

Promoter
59.9%
Foreign Institutions
7.5%
Mutual Funds
7.1%
Domestic Institutions
10.1%
Public
22.6%

Rubicon Research Latest News

17 APR 2026
15 APR 2026
15 APR 2026

Rubicon Research share price is ₹921.35 in NSE and ₹918.45 in BSE as on 21/4/2026.

Rubicon Research share price in the past 1-year return was 0. The Rubicon Research share hit a 1-year low of Rs. 570.75 and a 1-year high of Rs. 952.7.

The market cap of Rubicon Research is Rs. 15281.42 Cr. as of 21/4/2026.

The PE ratios of Rubicon Research is 96.67 as of 21/4/2026.

The PB ratios of Rubicon Research is 12.18 as of 21/4/2026

The Mutual Fund Shareholding in Rubicon Research was 7.14% at the end of 21/4/2026.

You can easily buy Rubicon Research shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Rubicon Research share price is ₹952.7 and ₹570.75 as of 21/4/2026.

Please be aware that Rubicon Research stock prices are subject to continuous fluctuations due to various factors.